Carcinoma of Unknown Primary site (CUP) in HEAD & NECK SURGERY

Similar documents
Management of Neck Metastasis from Unknown Primary

FINE NEEDLE ASPIRATION OF ENLARGED LYMPH NODE: Metastatic squamous cell carcinoma

Chapter 13: Mass in the Neck. Raymond P. Wood II:

The International Federation of Head and Neck Oncologic Societies. Current Concepts in Head and Neck Surgery and Oncology

Evaluation of Neck Mass. Disclosure. Learning Objectives 3/24/2014. Karen T. Pitman MD, FACS Banner MDACC, Gilbert AZ. Nothing to disclose

Cancers of unknown primary : Knowing the unknown. Prof. Ahmed Hossain Professor of Medicine SSMC

Objectives. Salivary Gland FNA: The Milan System. Role of Salivary Gland FNA 04/26/2018

Management guideline for patients with differentiated thyroid cancer. Teeraporn Ratanaanekchai ENT, KKU 17 October 2007

CERVICAL LYMPH NODES

Dr Nick McIvor. Dr John Chaplin. Head & Neck Surgeon Auckland City Hospital Auckland. Auckland Head & Neck Surgeon Gillies Hospital Auckland

Lecture 07. Lymphatic's of Head & Neck. By: Dr Farooq Amanullah Khan PMC

Cervical Lymph Nodes

Central Poorly Differentiated Adenocarcinoma of the Maxilla: Report of a Case

Head & Neck Clinical Sub Group. Network Agreed Imaging Guidelines for UAT and Thyroid Cancer. Measure Nos: 11-1C-105i & 11-1C-106i

Salivary Glands 3/7/2017

Case Scenario. 7/13/12 Anterior floor of mouth biopsy: Infiltrating squamous cell carcinoma, not completely excised.

Cystic carcinoma of the neck

Head and Neck Case 1 PATIENT HISTORY

Case Scenario 1. 7/13/12 Anterior floor of mouth biopsy: Infiltrating squamous cell carcinoma, not completely excised.

The many faces of extranodal lymphoma

See the latest estimates for new cases of salivary gland cancers in the US and what research is currently being done.

Salivary Gland Cytology

Management of unknown primary with neck node metastasis: Current evidence

From GTV to CTV: A Critical Step Towards Cure. Kenneth Hu, MD Associate Professor New York University Langone Medical Center June 21, 2017

Head and Neck Case Studies

HPV and Head and Neck Cancer: What it means for you and your patients

Catholic University of Louvain, St - Luc University Hospital Head and Neck Oncology Programme. Anatomopathology. Pathology 1 Sept.

Cervical Lymphadenopathy. Diagnosis and Management

NASAL SEPTUM ADENOID CYSTIC CARCINOMA: A CASE REPORT

EVERYTHING YOU WANTED TO KNOW ABOUT. Robin Billet, MA, CTR, Head & Neck CTAP Member May 9, 2013

Evaluation of Head and Neck Masses in Adults

Case Scenario 1. Pathology: Specimen type: Incisional biopsy of the glottis Histology: Moderately differentiated squamous cell carcinoma

Case Scenario 1 Worksheet. Primary Site C44.4 Morphology 8743/3 Laterality 0 Stage/ Prognostic Factors

QUIZZES WITH ANSWERS FOR COLLECTING CANCER DATA: PHARYNX

Los Angeles Society Of Pathologists Dr. Shobha Castelino Prabhu

My Journey into the World of Salivary Gland Sebaceous Neoplasms

performed to help sway the clinician in what the appropriate diagnosis is, which can substantially alter the treatment of management.

Head and Neck Squamous Subtypes

Case Scenario #1 Larynx

AJCC Staging of Head & Neck Cancer (7 th edition, 2010) -LIP & ORAL CAVITY-

QUIZZES WITH ANSWERS FOR COLLECTING CANCER DATA: PHARYNX

CLINICAL MEDICATION POLICY

What is head and neck cancer? How is head and neck cancer diagnosed and evaluated? How is head and neck cancer treated?

Case Scenario 1. Pathology report Specimen from mediastinoscopy Final Diagnosis : Metastatic small cell carcinoma with residual lymphatic tissue

Cancer in Estonia 2014

Disclosures. HPV and Head and Neck Cancer NONE 5/8/2018

Polymorphous Low-Grade. December 5 th, 2008

Head and Neck Cancer in FA: Risks, Prevention, Screening, & Treatment Options David I. Kutler, M.D., F.A.C.S.

Respiratory Interactive Session. Elaine Borg

Head and Neck Cancer. What is head and neck cancer?

SALIVARY GLAND DISEASES. Omar alnoubani MD,MRCS

Physician to Physician AJCC 8 th Edition. Head and Neck. Summary of Changes. AJCC Cancer Staging Manual, 7 th Ed. Head and Neck Chapters

Nasopharynx Cancer. 1 Feb Presenters: Dr Raghav Murali-Ganesh (Radiation Oncology Registrar) Dr Peter Luk (Pathology Registrar)

Volumi di trattamento del cavo orale

Head and Neck Pathology. Macroscopy and Dissection Dr Tim Bracey Consultant Pathologist (Derriford Hospital)

Approach to Thyroid Nodules

Oral Cancer Dr Christine Goodall Consultant Oral Surgeon University of Glasgow Dental School

Salivary Gland Imaging. Mary Scanlon MD FACR October 2016

Dr. Muhammad Shamim. Assistant Professor, Dept. of Surgery College of Medicine, Prince Sattam bin Abdulaziz University

Presented By Shirley Jordan Seay PhD, RN, CTR

Human Papillomavirus Testing in Head and Neck Carcinomas

Head and Neck Cancer How to recognize it in your office

NICE guideline Published: 10 February 2016 nice.org.uk/guidance/ng36

AJCC Cancer Staging 8 th edition. Lip and Oral Cavity Oropharynx (p16 -) and Hypopharynx Larynx

1. Written information to patient /GP: fax ASAP to GP & offer copy of consultation letter.

What is ACC? (Adenoid Cystic Carcinoma)

Salivary ultrasound. Dr T J Beale Royal National Throat Nose & Ear and UCLH Hospitals London UK

Principles of Surgical Oncology. Winnie Achilles Tierklinik Hollabrunn Lastenstrasse Hollabrunn

The importance of knowing the lymphatic spread patterns of head and neck cancer for accurate nodal staging on CT: A practical schematic guide

Head and Neck Pathology Macroscopy and Dissection Dr Tim Bracey

Head & Neck Contouring

RADIO- AND RADIOCHEMOTHERAPY OF HEAD AND NECK TUMORS. Zoltán Takácsi-Nagy PhD Department of Radiotherapy National Institute of Oncology, Budapest 1.

2018 SEER Solid Tumor Manual 2018 KCR SPRING TRAINING

Merkel Cell Carcinoma Case # 2

CLINICAL PRESENTATION AND RADIOLOGY QUIZ QUESTION

Radiology Pathology Conference

The following images were all acquired using a CTI Biograph

SEER Summary Stage Still Here!

Appendix 1: QIICR Iowa Head and Neck Clinical Data DICOM SR Template

PET/CT Frequently Asked Questions

6. Cervical Lymph Nodes and Unknown Primary Tumors of the Head and Neck

Neck lumps in children

Cytologic Evaluation of the Enlarged Neck Node: FNAC Utility in Metastatic Neck Disease

4/22/2010. Hakan Korkmaz, MD Assoc. Prof. of Otolaryngology Ankara Dıșkapı Training Hospital-Turkey.

Thyroid INTRODUCTION ANATOMY SUMMARY OF CHANGES

Shadow because the air

Head & Neck Squamous Carcinoma: Artifacts, Challenges, and Controversies. Agenda

Neck mass Evaluation & Management OTOLARYNGOLOGY, HEAD & NECK SURGICAL ONCOLOGY

ANALYSIS OF SECONDARY NECK NODES IN MALIGNANCIES OF UPPER AERODIGESTIVE TRACT

DISORDERS OF THE SALIVARY GLANDS Neoplasms Dr.M.Baskaran Selvapathy S IV

Surgery in Head and neck cancers.principles. Dr Diptendra K Sarkar MS,DNB,FRCS Consultant surgeon,ipgmer

C. Douglas Phillips, MD FACR Director of Head and Neck Imaging Weill Cornell Medical Center NewYork Presbyterian Hospital

Head & Neck Staging. Donna M. Gress, RHIT, CTR Technical Editor, AJCC Cancer Staging Manual First Author, Chapter 1: Principles of Cancer Staging

Parotid Disease Case Discussions. Valerie Jefford November 28, 2002

AJCC 8 th Edition Staging. Head & Neck Staging. Learning Objectives. This webinar is sponsored by. the Centers for Disease Control and Prevention.

64 y.o. F with CLL and leg tumour

Case Scenario 1. 4/19/13 Bone Scan: No scintigraphic findings to suggest skeletal metastases.

Evaluation and Management of Thyroid Nodules. Nick Vernetti, MD, FACE Palm Medical Group Las Vegas, Nevada

Pathology of Sarcoma ELEANOR CHEN, MD, PHD, ASSISTANT PROFESSOR DEPARTMENT OF PATHOLOGY UNIVERSITY OF WASHINGTON

Take Home Quiz 1 Please complete the quiz below prior to the session. Use the Multiple Primary and Histology Rules

Transcription:

Carcinoma of Unknown Primary site (CUP) in HEAD & NECK SURGERY SEARCHING FOR THE PRIMARY? P r o f J P P r e t o r i u s H e a d : C l i n i c a l U n i t C r i t i c a l C a r e U n i v e r s i t y O f P r e t o r i a & S t e v e B i k o A c a d e m i c H o s p i t a l

YES! CUP in general has:.. Dismal prognosis! 7 th most common malignancy No primary site in 3 5% of patients with metastatic cancer 3 4 months mean survival <25% alive at 1 year <10% alive at 5 years Make up 15% of metastatic cervical lymph nodes Usually affect supraclavicular or lower jugular nodes Are usually adenocarcinoma CUP in Head & Neck has: SCC is most common 90% 10% of cases with metastatic SCC has no primary 1 3% of new cases of SCC annually present as CUP AdenoCA in upper neck Thyroid Salivary glands Parathyroid Metastases in upper & mid neck good prognosis on Rx

YES! CUP below the clavicles: CUP in Head & Neck: Generally incurable due to late presentation Represents distant metastases Brief longevity?chemotherapy Mx is directed at cure Locoregional disease Treat aggressively to prevent local recurrence To prevent primary emergence Imperative to find the primary

How to find the primary.comprehensive evaluation essential.to treat H & N CUP lesions optimally. Comprehensive history Extensive physical examination Appropriate imaging Full panendoscopy plus biopsies

The history E x p o s u r e t o etiological factors to carcinogens Occupational hazards C o u n t r y o f o r i g i n P r e v i o u s m a l i g n a n c i e s D e r m a t o l o g i c a l h i s t o r y A n y H & N s y m p t o m s pain, trismus, odynophagia, dysphagia, haemoptysis, hoarseness, epistaxis, nasal congestion, aspiration P a i n l e s s n e c k m a s s. w e e k s. m o n t h s

Case History 43 year old male Smokes 20 pack years, uses alcohol, good general condition HIV non-reactive 9/12 rapidly enlarging submental tumour Submental but slightly to the left, firm 15x15 cm mass. 3 Round, umbilicated areas of ulceration with central necrosis. Mass mobile. Floor of mouth clear. Rest of neck clinically non-significant nodes. CT-scan: ring enhancing mass in multiple cervical lymph nodes FNA: SCC Biopsy: poorly differentiated, infiltrating, keratinizing SCC TxN3Mo?CUP

The physical examination T h o r o u g h T o t a l H & N r e g i o n N e w s k i n l e s i o n s o r s c a r s C r a n i a l n e r v e s A L L a n a t o m i c a l s t r u c t u r e s Scalp, skin, ears, nose, nasal vestibules, salivary glands, oral cavity, oropharynx, nasopharynx, hypopharynx, larynx S u b m u c o s a l l e s i o n s. p a l p a t i o n E U A H i g h - y i e l d a n a t o m i c a l s i t e s B i o p s y s a m p l e s

DIFFERENTIAL DIAGNOSIS OF NECK MASSES 15% Inflammatory/Congenital Etiology in Adults (Excluding thyroid) 15% Benign 85% Neoplastic 15% Primary Lymphoma/Salivary 85% Malignant 15% From below the clavicles 85% Metastatic 85% Above the clavicles

The neck.all zones S y s t e m a t i c e x a m i n a t i o n S i z e a n d n u m b e r F i x a t i o n V i t a l s t r u c t u r e s U n i l a t e r a l. i p s i l a t e r a l p r i m a r y B i l a t e r a l. m i d l i n e p r i m a r y L y m p h a t i c d r a i n a g e p a t t e r n s A r e a o f p r i m a r y i n d i c a t e d b y l e v e l o f l y m p h nodes affected

Regional lymph node groups draining a specific primary site as first echelon lymph nodes 20/03/2004

Imaging 1 st C T a n d / o r M R I w i t h c o n t r a s t 2 nd F D G - P E T o r i n t e g r a t e d P E T / C T Before panendoscopy Guide biopsies Avoid false positive FDG avidity after biopsies

Initial Dx 1. 1. FNA 2. 2. Tru-cut Histology report 1. FNA SCC 2. Tru-cut: poorly differentiated infiltrating keratinizing squamous cell carcinoma.. 3. After personal communication with pathologist..consider.?salivary gland primary Epidermoid Adenoid cystic Low grade polymorphous adenoca Plan: fresh tissue fore more immunohistochemical evaluations eg PAS, PAS-d, SMA 4. Perform panendoscopy

Panendoscopy D i r e c t i n s p e c t i o n a n d p a l p a t i o n F l e x i b l e f i b e r o p t i c e n d o s c o p y Sinuses, nasal cavity, nasopharynx, base of tongue, hypopharynx, larynx Directed biopsies of high-yield sites, suspicious areas, contact bleeding B i l a t e r a l t o n s i l l e c t o m y E s o p h a g o s c o p y

EUA Procedure: Panendoscopy Adenotonsillectomy Multiple biopsies Findings: Left base of tongue smooth, non-ulcerating mass extending to palatoglossal fold. Left tonsil superficial ulceration Adenoid tissue(minimal) in Nasopharynx Normal Right base of tongue Normal hypopharynx, pyriform fossae, post cricoid area, posterior pharyngeal wall Bimanual palpation of floor of mouth no clear submucous pathology Normal larynx and trachea up to the carina Normal oesophagus in its entirety

EUA Histology report Direct inspection Bimanual palpation Fibre optic endoscopy Esophagoscopy Multiple biopsies No evidence of epithelial dysplasia or of invasive malignancy in any of the sections examined of the 12 biopsies submitted. Tongue base L & R Tonsils L& R Adenoids

Newer Diagnostic Aids 1. H P V h u m a n p a p i l l o m a v i r u s : p o s i t i v e i n > 5 0 % o f o r o f a r y n g e a l S C C t u m o u r s vs n o n - o r o f a r y n g e a l t u m o u r s. 2. P 1 6 v a l u a b l e i m m u n o h i s t o c h e m i c a l a n a l y s i s t o i d e n t i f y H P V a s s o c i a t e d t u m o u r s. 3. E p s t e i n B a r r v i r u s s e n s i t i v e P C R m a r k e r f o r n a s o p h a r y n g e a l C A. 4. T i m e - r e s o l v e d l a s e r - i n d u c e d f l u o r e s c e n c e s p e c t r o s c o p y n o n i n v a s i v e, c a n d i s c r i m i n a t e b e t w e e n m a l i g n a n t a n d n o n - m a l i g n a n t t i s s u e. 5. I m m u n o h i s t o c h e m i c a l s t a i n i n g f o r k e r a t i n s, l e u k o c y t e c o m m o n a n t i g e n a n d S 1 0 0 e x p r e s s e d i n m e l a n o m a 6. G e n e e x p r e s s i o n p r o f i l i n g t o i d e n t i f y s i t e o f o r i g i n o f a d e n o C A C U P l e s i o n s 7. E l e c t r o n m i c r o s c o p y H & N C U P : d e s m o s o m e s a n d t o n o f i l a m e n t s a r e c h a r a c t e r i s t i c o f S C C

Final Pathological Information Personal communication with your pathologist! After more staining and re-evaluation, found: Intermediate cells Squamous or epidermoid cells Mucus-producing cells Final diagnosis: NOT A CUP LESION Mucoepidermoid CA high grade. From sublingual glands? Auclair and Brandwein classification assessing for: Nerve and blood vessel infiltration Cellular atypia >4 mitoses / 10x magnification Mucous cyst content Bone infiltration Necrosis

Treatment Options for H&N SCC CUP 1. N1 and N2a disease 2. Stage 2b or higher 3. Primary emergence from high yield sites 1. a)single modality RTx with IMRT technique to spare the mucosa b)formal neck dissection in selected cases 2. a)concurrent CTX-RTx with IMRT technique b)surgery reserved for persistent / recurrent disease after RTx c)formal Neck dissection and post op RTx with or without CTx is a second option 3. Radiation with/without CTx to minimize primary recurrence

Conclusion YES, search for the primary and treat aggressively. Locoregional control in H&N SCC CUP lesions: Two components: Controlling neck disease Preventing primary recurrence Prognosis determined by clinical stage at Dx Combination therapy best to contain neck recurrence + emergence of primary tumours SCC CUP overall survival comparable to that of patients with known primary 5 Year survival as high as 30-50%

20/03/2004

20/03/2004

CUP / CARCINOMA OF UNKNOWN PRIMARY ORIGIN Plan of Examination - patient presenting with a neck mass Skin scalp, face, ears, neck Nose inside Oral cavity -?EUA Salivary glands and Thyroid Arms, chest wall, breasts Abdomen and genitalia Transilluminate sinuses Panendoscopy - nasopharynx, larynx, oesophagus - biopsy primary / blind Lymph nodes - FNA or needle biopsy - Do not excise lymphnode primarily TB Lymphoma 20/03/2004

YES!!! CUP in general has:..dismal prognosis.. 7 th most common malignancy No primary site in 3 5% of patients with metastatic cancer 3 4 months mean survival <25% alive at 1 year <10% alive at 5 years Make up 15% of metastatic cervical lymph nodes Usually affect supraclavicular or lower jugular nodes Are usually adenocarcinoma

YES!!! CUP in Head & Neck has: 10% of cases with metastatic SCC has no primary 1 3% of new cases of SCC annually present as CUP Squamous cell cancer is the most likely histological finding (90%) in patients with: Cervical metastatic lymphadenopathy Adenocarcinoma Melanoma or even Anaplastic tumours may also be found

Markers